Free Trial
NYSE:GRDN

Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis

Guardian Pharmacy Services logo
$25.83 -0.46 (-1.75%)
Closing price 03:59 PM Eastern
Extended Trading
$25.80 -0.03 (-0.14%)
As of 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Guardian Pharmacy Services Stock (NYSE:GRDN)

Key Stats

Today's Range
$25.75
$26.76
50-Day Range
$19.65
$26.24
52-Week Range
$14.16
$26.91
Volume
417,788 shs
Average Volume
206,149 shs
Market Capitalization
$1.64 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.67
Consensus Rating
Buy

Company Overview

Guardian Pharmacy Services Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

GRDN MarketRank™: 

Guardian Pharmacy Services scored higher than 18% of companies evaluated by MarketBeat, and ranked 875th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Guardian Pharmacy Services are expected to decrease by -3.45% in the coming year, from $0.87 to $0.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Guardian Pharmacy Services is -16.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Guardian Pharmacy Services is -16.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Guardian Pharmacy Services has a P/B Ratio of 9.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for GRDN.
  • Dividend Yield

    Guardian Pharmacy Services does not currently pay a dividend.

  • Dividend Growth

    Guardian Pharmacy Services does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for GRDN.
  • News Sentiment

    Guardian Pharmacy Services has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Guardian Pharmacy Services this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for GRDN on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Guardian Pharmacy Services to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Guardian Pharmacy Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $228,713,426.00 in company stock.

  • Percentage Held by Insiders

    63.71% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Guardian Pharmacy Services' insider trading history.
Receive GRDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter.

GRDN Stock News Headlines

Guardian Pharmacy: Q2 Earnings Snapshot
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.tc pixel
See More Headlines

GRDN Stock Analysis - Frequently Asked Questions

Guardian Pharmacy Services' stock was trading at $20.26 at the start of the year. Since then, GRDN stock has increased by 27.5% and is now trading at $25.83.

Guardian Pharmacy Services, Inc. (NYSE:GRDN) announced its earnings results on Monday, May, 12th. The company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by $0.01. The firm earned $329.31 million during the quarter, compared to the consensus estimate of $321.21 million. Guardian Pharmacy Services had a negative trailing twelve-month return on equity of 52.41% and a negative net margin of 6.90%.
Read the conference call transcript
.

Guardian Pharmacy Services (GRDN) raised $102 million in an initial public offering (IPO) on Thursday, September 26th 2024. The company issued 6,800,000 shares at $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities served as the underwriters for the IPO.

Top institutional shareholders of Guardian Pharmacy Services include Brown Advisory Inc. (2.66%), Franklin Resources Inc. (1.54%), TimesSquare Capital Management LLC (1.29%) and New York State Common Retirement Fund (0.55%). Insiders that own company stock include William E Bindley, Thomas J Salentine Jr, Fred Burke, David K Morris, Kendall Forbes, John Ackerman and Steven D Cosler.
View institutional ownership trends
.

Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META).

Company Calendar

Last Earnings
5/12/2025
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Retail
Current Symbol
NYSE:GRDN
Previous Symbol
NYSE:GRDN
CIK
1802255
Fax
N/A
Employees
3,400
Year Founded
N/A

Price Target and Rating

High Price Target
$28.00
Low Price Target
$21.00
Potential Upside/Downside
-0.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
29.69
P/E Growth
N/A
Net Income
-$87.29 million
Net Margins
-6.90%
Pretax Margin
-4.80%
Return on Equity
-52.41%
Return on Assets
-24.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.18
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$1.23 billion
Price / Sales
1.33
Cash Flow
$0.25 per share
Price / Cash Flow
105.40
Book Value
$2.84 per share
Price / Book
9.10

Miscellaneous

Outstanding Shares
63,320,000
Free Float
22,967,000
Market Cap
$1.64 billion
Optionable
N/A
Beta
N/A

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:GRDN) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners